Galectin Issues Statement on Yesterday's Sell Off, Says Attributed To Negative Social Media Posts and Misinterpretation
July 30, 2014 at 09:09 AM EDT
Press Release Galectin Therapeutics (Nasdaq: GALT), the leading developer of therapeutics that target galectin proteins to treat ...